Physiotherapeutic treatment associated with the use of botulinum toxin in patients with spastic cerebral palsy: an integrative review
DOI:
https://doi.org/10.33448/rsd-v10i15.22756Keywords:
Physical Therapy; Botulinum Toxin; Botulinum Toxins Type A; Cerebral Palsy; Muscle spasticity.Abstract
Introduction: Cerebral palsy (CP) is characterized by brain damage in the early stages of development, and may be associated with spasticity. In view of the normalization of muscle tone, botulinum toxin (BT) is an alternative to provide greater relaxation of the muscles in patients with spasticity. Physiotherapy treatment associated with the use of toxin could enhance the treatment for spasticity. Objective: To review the literature on physical therapy treatment associated with the use of TB in patients with spastic cerebral palsy. Methods: A literature review was conducted in PubMed, LILACS, BVS and SciELO databases, from 2010 to 2020. The descriptors used were: cerebral palsy, spasticity, botulinum toxin and physical therapy. Results: 77 articles were found, however, 8 were excluded for being duplicates and 60 for not meeting the inclusion criteria, being included 9 articles in this review. In the reviewed studies, TB when associated with physical therapy treatments, promoted the relaxation of spastic muscles, reduced pain, favored the use of orthoses, increased the range of motion, improving the quality and life expectancy of these individuals. Final considerations: The use of TB associated with physical therapy provides improvement on spasticity and functionality in patients with spastic CP.
References
Aguilar-Rebolledo, F., Hernández-Sánchez, J., Rayo-Mares, D., Soriano, F. F., García-Muñoz, L., Ruiz-Ponce, J., Garrido-Ramírez, E., (2001) Toxina botulínica como tratamiento de la espasticidad y distonía en la parálisis cerebral infantil. Gac Med Mex. ;137(5):403-411.
Carbonari de Faria, T. C., Masiero. D., Spósito, M., Saad, M. (2001). A avaliação do uso da toxina botulínica A e da cinesioterapia na melhora da marcha do portador de paralisia cerebral do tipo hemiparético. ActraFisiatrica.8(3), 1-6.
Cesa, CC, Motta, HB, & Brandão, L. (2020). Análise conversacional de crianças com paralisia cerebral: estudo de casos múltiplos. Research, Society and Development , 9 (6), e133963580. https://doi.org/10.33448/rsd-v9i6.3580
Chaléat-Valayer, E., Parratte, B., Colin, C., Denis, A., Oudin, S., Bérard, C., Bernard, J. C., Bourg, V., Deleplanque, B., Dulieu, I., Evrard, P., Filipetti, P., Flurin, V., Gallien, P., Héron-Long, B., Hodgkinson, I., Husson, I., Jaisson-Hot, I., Maupas, E., Meurin, F., … Marque, P. (2011). A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 15(5), 439–448. https://doi.org/10.1016/j.ejpn.2010.04.006
Esquenazi, A., Stoquart, G., Hedera, P., Jacinto, L. J., Dimanico, U., Constant-Boyer, F., Brashear, A., Grandoulier, A. S., Vilain, C., Picaut, P., & Gracies, J. M. (2020). Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial. PM & R : the journal of injury, function, and rehabilitation, 12(9), 853–860. https://doi.org/10.1002/pmrj.12348
Faria, S. S., & Pedro Leme Silva, P. L. S. P. L. S. (2014). Revisão Sistemática sobre Tratamento Medicamentoso para Dor no Membro Fantasma. Revista Neurociências, 22(2), 177–188. https://doi.org/10.34024/rnc.2014.v22.8091
Figueiredo, B. Q. de, Ricardo Neto, A.., Nogueira, C. F. R., Fernandes, R. A., & Almeida, M. G. (2021). Tratamento das sequelas do Acidente Cerebrovascular (AVC) com toxina botulínica: uma revisão da literatura. Research, Society and Development , 10 (8), e56610817880. https://doi.org/10.33448/rsd-v10i8.17880
Franco, C. Buarque, P., Larissa, de C., Pontes, L. da S., & Sousa, E. de J. (2006). Avaliação da amplitude articular do tornozelo em crianças com paralisia cerebral após a aplicação de toxina botulínica seguida de fisioterapia. Revista Paraense de Medicina, 20(3), 43-49. Recuperado em 01 de novembro de 2021, de http://scielo.iec.gov.br/scielo.php?script=sci_arttext&pid=S0101-59072006000300009&lng=pt&tlng=pt.
Gallagher, S., Phadke, C. P., Ismail, F., & Boulias, C. (2015). Physical therapy for an adult with chronic stroke after botulinum toxin injection for spasticity: a case report. Physiotherapy Canada. Physiotherapie Canada, 67(1), 65–68. https://doi.org/10.3138/ptc.2013-73
Gomes, C. de O., & Golin, M. O. (2013). Tratamento Fisioterapêutico Na Paralisia Cerebral Tetraparesia Espástica, Segundo Conceito Bobath. Revista Neurociências, 21(2), 278–285. https://doi.org/10.34024/rnc.2013.v21.8293
Multani, I., Manji, J., Hastings-Ison, T., Khot, A., & Graham, K. (2019). Botulinum Toxin in the Management of Children with Cerebral Palsy. Paediatric drugs, 21(4), 261–281. https://doi.org/10.1007/s40272-019-00344-8.
Resende, C. M. G., do, Nascimento. V. F., & S., Leite. J. M. R. (2005). Eficácia da toxina botulínica tipo-A associada a fisioterapia em uma criança hemiplégica espástica. Revista Neurociências, 13(1), 17–20. https://doi.org/10.34024/rnc.2005.v13.8840
Rodríguez-Reyes, G., Alessi-Montero, A., Díaz-Martínez, L., Miranda-Duarte, A., & Pérez-Sanpablo, A. I. (2010). Botulinum toxin, physical and occupational therapy, and neuromuscular electrical stimulation to treat spastic upper limb of children with cerebral palsy: a pilot study. Artificial organs, 34(3), 230–234. https://doi.org/10.1111/j.1525-1594.2009.00768.x
Sáinz-Pelayo, M. P., Albu, S., Murillo, N., & Benito-Penalva, J. (2020). Espasticidad en la patología neurológica. Actualización sobre mecanismos fisiopatológicos, avances en el diagnóstico y tratamiento [Spasticity in neurological pathologies. An update on the pathophysiological mechanisms, advances in diagnosis and treatment]. Revista de neurologia, 70(12), 453–460. https://doi.org/10.33588/rn.7012.2019474
Serrera-Figallo, M. A., Ruiz-de-León-Hernández, G., Torres-Lagares, D., Castro-Araya, A., Torres-Ferrerosa, O., Hernández-Pacheco, E., & Gutierrez-Perez, J. L. (2020). Use of Botulinum Toxin in Orofacial Clinical Practice. Toxins, 12(2), 112. https://doi.org/10.3390/toxins12020112.
Schasfoort, F., Dallmeijer, A., Pangalila, R., Catsman, C., Stam, H., Becher, J., Steyerberg, E., Polinder, S., & Bussmann, J. (2018). Value of botulinum toxin injections preceding a comprehensive rehabilitation period for children with spastic cerebral palsy: A cost-effectiveness study. Journal of rehabilitation medicine, 50(1), 22–29. https://doi.org/10.2340/16501977-2267
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Danielle Patricia de Souza; Mariana Medeiros Gomes Peixoto; Sabrina de Melo Oliveira; Breno Azevedo; Juliana Paulino Dantas da Silva Agranemam; Giovanna Cavalcanti; Taylline Karolayne Gusmão de Oliveira; Bárbara Bernardo Figueirêdo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
